Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
NCT06481306Phase 2Recruiting
- Sponsor
- Bristol Myers Squibb
- Start
- Jul 2024
- Primary completion
- Jan 2027
- Countries
- 5
01
Overview
A Phase 2 trial of BMS-986470 in sickle cell disease (SCD), sponsored by Bristol Myers Squibb. Started Jul 2024; status: recruiting.
02
Drugs
BMS-986470
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT06481306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06481306.